Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is ₺44.528,86, with a 24-hour trading volume of ₺291,48M. The asset's market cap is ₺39,7T, after moving -0.44% in the last day.
Tokenized Eli Lilly And Co is trading at ₺44.740,29, with a tokenized market cap of ₺249,39M and a 24-hour trading volume of ₺89,67M. The tokenized asset has moved 2.21% in the past 24 hours.